What is the next big innovation coming to the Life Sciences sector?
October 16th 2024
In our recent Life Sciences roundtable, Compass Carter Osborne welcomed a cohort of industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from.
Addressing a broad range of topics, panelists addressed questions on biotech funding bounce-back; investment appetite in innovative technologies; quantum computing and AI; driving positive outcomes for the sector; and much more.
Key areas of discussion covered off:
Which innovations might have the biggest positive impact on the sector in the next five years
Investor standpoint: which technologies are you most likely to invest in, and why?
Quantum Computing – hype or hope?
What can the Life Sciences sector do to ensure the potential for innovation through computing is delivered?
Biotech funding cycle bounce-back
Therapeutic or devices in 2025 – target markets
The CCO team extend their sincere thanks to the following participants:
Geoff Dobson (Discussion Chair)
Matthew Fyfe, Storm Therapeutics
Prashant Shah, O2h Discovery
Dr Iris Good, Plural
Jerry Wu, TusPark Holdings
Aline Charpentier, Bruntwood SciTech
Sebastian Stachowiak, ICE Biopharma
Colin Sims, Adthera Bio
Dr Suhail Nurbhai, Mission Therapeutics
Usman “Oz” Azam, Inspirna
Stephen Dowd, Confo Therapeutics
Tarquin Bennett-Coles, Compass Carter Osborne
Martin Anderson, Carrot Recruitment
Alex Boulger, Compass Carter Osborne
To obtain a copy of the full report and the responses to each question, download your copy below.
Are you seeking a trusted partner to support your executive search in healthcare and life sciences?
As a trusted advisor, we bring decades of executive search experience and a proven track record of success across our dedicated sectors. Our investor clients rely on us time and again to build exceptional leadership teams that drive growth and deliver results.
